Tag: SA Pharma

  • Semaglutide Compounding Dispute: Novo Nordisk Heads To Court

    Danish pharmaceutical giant Novo Nordisk is taking compounding pharmacy iDexis to the Pretoria High Court. The highly anticipated legal battle will take place on June 10. The case focuses on the unauthorised scale production of semaglutide-based weight-loss injections. Novo Nordisk wants the court to stop iDexis from manufacturing, advertising, and distributing these products. The global firm alleges that iDexis is…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • SA Pharma Localisation Faces Foreign Investor Pressure

    South Africa’s pharmaceutical sector has become a major industrial battleground. The government is pushing hard to localise production and boost public procurement. It also wants to rebuild domestic capacity. However, outside forces are complicating these goals. Trade, Industry and Competition Minister Parks Tau delivered this warning at a recent stakeholder engagement. He noted that foreign investors remain highly interested in…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in